Lyell Immunopharma (LYEL) FCF Margin (2020 - 2025)
Historic FCF Margin for Lyell Immunopharma (LYEL) over the last 6 years, with Q3 2025 value amounting to 190926.67%.
- Lyell Immunopharma's FCF Margin fell 876884300.0% to 190926.67% in Q3 2025 from the same period last year, while for Sep 2025 it was 403743.9%, marking a year-over-year decrease of 1557566000.0%. This contributed to the annual value of 266980.33% for FY2024, which is 1389957100.0% down from last year.
- Per Lyell Immunopharma's latest filing, its FCF Margin stood at 190926.67% for Q3 2025, which was down 876884300.0% from 432825.0% recorded in Q2 2025.
- Over the past 5 years, Lyell Immunopharma's FCF Margin peaked at 92.69% during Q4 2022, and registered a low of 1407866.67% during Q1 2024.
- In the last 5 years, Lyell Immunopharma's FCF Margin had a median value of 148496.3% in 2023 and averaged 298857.46%.
- In the last 5 years, Lyell Immunopharma's FCF Margin surged by 2000000000bps in 2023 and then tumbled by 2000000000bps in 2024.
- Lyell Immunopharma's FCF Margin (Quarter) stood at 1540.79% in 2021, then skyrocketed by 94bps to 92.69% in 2022, then tumbled by -337336bps to 312769.23% in 2023, then plummeted by -37bps to 429872.73% in 2024, then skyrocketed by 56bps to 190926.67% in 2025.
- Its FCF Margin stands at 190926.67% for Q3 2025, versus 432825.0% for Q2 2025 and 785485.71% for Q1 2025.